Vnitr Lek 2013, 59(11):955-960

Prevalence of diabetic retinopathy and distal symmetrical diabetic polyneuropathy, and glomerular filtration screening upon the diagnosis of type 2 diabetes mellitus - a cohort study

L. Buková1,*, P. Galajda2, M. Mokáň2
1 Diabetologická ambulancia II. internej kliniky SZÚ a FNsP F. D. Roosevelta Banská Bystrica, Slovenská republika, prednosta MUDr. Ľubomír Skladaný, PhD., h. doc.
2 I. interná klinika Jesseniovej lekárskej fakulty UK a UN Martin, Slovenská republika, prednosta prof. MUDr. Marián Mokáň, DrSc., FRCP Edin

The prospective cohort study analyzes the prevalence of microvascular complications at the time of diagnosis type 2 diabetes (DM 2). We were monitoring 200 outpatients (117 men and 83 women, aged from 30 to 92 years) with newly diagnosed and previously untreated type 2 diabetes mellitus during the period of August 2007 - August 2011 accidentally sending GP or internists. Prevalence of diabetic retinopathy in men was 0.85% and in women 1.2%. The prevalence of diabetic distal symetric polyneuropathy in men was 53% and in women 62%. The median of glomerular filtration based on a simplified MDRD-4 equation (according to the study Modification of Diet in Renal Disease) was 1.27 ± 0.6 ml/s/1.73 m2 for men and 1.05 ± 0.32 ml/s/1.73 m2 for women. At baseline, 16.6% of men and 46.2% of women enrolled in our cohort study had glomerular filtration rate < 1 ml/s/1.73 m2.

Keywords: newly diagnosed type 2 diabetes mellitus; diabetic retinopathy; diabetic neuropathy; glomerular filtration rate

Received: February 23, 2013; Accepted: July 21, 2013; Published: November 1, 2013  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Buková L, Galajda P, Mokáň M. Prevalence of diabetic retinopathy and distal symmetrical diabetic polyneuropathy, and glomerular filtration screening upon the diagnosis of type 2 diabetes mellitus - a cohort study. Vnitr Lek. 2013;59(11):955-960.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Buková L, Galajda P, Mokáň M. The prevalence of coronary heart disease, stroke and selected co-morbidities in patients with newly diagnosed type 2 diabetes - population-based cohort study of outpatients. Acta Medica Martiniana 2013; 13: 33-43. Go to original source...
    2. Mancia G, De Backer G, Dominiczak L et al. Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESH). Eur Heart J 2007; 28: 1462-1536.
    3. Okša A, Ponťuch P, Spustová V et al. Diabetická nefropatia - diagnostika, prevencia a liečba: odporúčané postupy Slovenskej nefrologickej spoločnosti a Slovenskej diabetologickej spoločnosti. Diabetes a obezita 2012; 24: 99-107.
    4. de Fine Olivarius N, Nielsen NV, Andreasen AH. Diabetic retinopathy in newly diagnosed middle-aged and elderly diabetic patients: prevalence and interrelationship with microalbuminuria and triglycerides. Graefes Arch Clin Exp Ophthalmol 2001; 239: 664-672. Go to original source... Go to PubMed...
    5. Tapp RJ, Shaw JE, Harper CA et al. AusDiab Study Group: The prevalence of and factors associated with diabetic retinopathy in the Australian population. Diabetes Care 2003; 26: 1731-1737. Go to original source... Go to PubMed...
    6. Rema M, Deepa R, Mohan V. Prevalence of retinopathy at diagnosis among type 2 diabetic patients attending a diabetic centre in south India. Br J Ophthalmol 2000; 84: 1058-1060. Go to original source... Go to PubMed...
    7. Talu S, Kaucsar E, Soreanu A. Diabetic retinopathy in newly diagnosed patients with type II diabetes mellitus (in Romanian). Oftalmologia 2002; 54: 27-30. Go to PubMed...
    8. Homoud Al-Zuabi, Yaqoub Al-Tammar, Reem Al-Moataz et al. Retinopathy in newly diagnosed type 2 diabetes mellitus. Med Princ Pract 2005; 14: 293-296. Go to original source... Go to PubMed...
    9. Dyck PJ. Diabetic polyneuropathies, retinopathy and nefropathy increased in newly diagnosed diabetes. Diab Care 2012; 35: 584-591. Go to original source... Go to PubMed...
    10. Krahulec B. Diabetická neuropatia. In: Mokáň M, Martinka E, Galajda P et al (eds). Diabetes mellitus a vybrané metabolické ochorenia. Martin: Vydavateľstvo P + M 2008: 588-607.
    11. Tesfaye S, Chaturvedi N, Eaton SE et al. Vascular risk factors and diabetic neuropathy. N Engl J Med 2005; 352: 341-350. Go to original source... Go to PubMed...
    12. Praddepa R, Rema M, Vignesh J et al. Prevalence and risk factors for diabetic neuropathy in a urban south Indian population: The Chennai Urban Rural Epidemiology Study (CURRES-55). Diabet Med 2008; 4: 407-412. Go to original source... Go to PubMed...
    13. Bruce SG, Young TK. Prevalence and Risk Factors for Neuropathy in a Canadians First Nation Community. Diab Care 2008; 9: 1837-1841. Go to original source... Go to PubMed...
    14. Morkeid K, Ali L, Hussain. A Risk factors and prevalence of diabetic peripheral neuropathy. A study of type 2 diabetic outpatients in Bangladesh. Int J Diabetes Dev Ctries 2010; 1: 11-17. Go to original source... Go to PubMed...
    15. Bruce SG, Young TK. Prevalence and risk factors for neuropathy in a Canadian First Nation Community. Diab Care 2008; 9: 1837-1841. Go to original source... Go to PubMed...
    16. Dutta A, Naorem S, Singh TP et al. Prevalence of peripheral neuropathy in newly diagnosed type 2. diabetes. Int J Diabetes Dev Ctries 2002; 25: 30-33. Go to original source...
    17. Viswanathan V, Tilak P, Kumpatla S. Risk factors associated with the development of overt nephropathy in type 2 diabetes patients: A 12 years observational study. Indian J Med Res 2012; 136: 46-53.
    18. Alwakeel JS, Isnani AC, Alsuwaida A et al. Factors affecting the progression of diabetic nephropathy and its complications. A single-center experience in Saudi Arabia. Ann Saudi Med 2011; 3: 236-242. Go to original source... Go to PubMed...
    19. Fong DS, Aiello LP, Ferris FL. Diabetic retinopathy. Diab Care 2004; 27: 2540-2553. Go to original source... Go to PubMed...
    20. Kalvodová B. Screening diabetické retinopatie. In: Rozsíval P et al (eds). Trendy soudobé oftalmologie, svazek 3. Praha: Galén 2006.
    21. Kalvodová B. Diabetická retinopatie - komentář. Med Prom 2004; 5: 31-34.
    22. Beszédešová N. Screening diabetickej retinopatie. Interní Med 2007; 9: 345-348.
    23. Dia život. Dostupné z: http://www.diazivot.hcz/data/standardy/2-nefropatie.pdf.
    24. Pafčugová J, Kvapil M. Klinický význam vyšetření mikroalbuminurie. In: Kvapil M et al (eds). Diabetologie 2012. Praha: Triton 2012: 209-217.
    25. Ponťuch P. Diabetická nefropatia. In: Mokáň M, Martinka E, Galajda P et al (eds). Diabetes mellitus a vybrané metabolické ochorenia. Martin: Vydavateľstvo P + M 2008: 552-564.
    26. Dzúrik R, Spustová V. Vyšetrenia chorôb obličiek. In: Dzúrik R et al (eds). Štandardná klinickobiochemická diagnostika. Martin: Osveta 1996: 375-380.
    27. Ponťuch P, Lištiaková D, Černá K et al. Výskyt mikroalbuminúrie, klinickej proteinúrie a artériovej hypertenzie u diabetikov 2. typu na Slovensku. Diabetes a obezita 2004; 4: 41-48.

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.